FDA’s Makary: No immediate change scheduled for the availability of mifepristone

Food and Drug Administration Commissioner Marty Makary said in a recent interview that he had “no preconceived plans” to modify the policies concerning the abortion pill at Miffepristone, which is designed to end a pregnancy in the first 10 weeks.

“We have a continuous examination of the security data on mifepristone, which is a requirement of previous administrations,” said Makary in an interview with Politico. “You must always be open -minded. You have to listen to different opinions and make decisions according to what you think is the right thing to do.”

His comments reflect those he made during the Summit of the World Economy of Semaor in April.

During the summit, Makary said he had “not intended to act” which would restrict the availability of the drug to abortion, but warned that the agency would not hesitate to act if the data suggested that there was a security problem.

Miffepristone abortion pill triggers a new pro-life debate while some doctors stress security problems

Mifepristone’s drug boxes are sitting on a shelf at the West Alabama Women’s Center in Tuscaloosa, Alberta, on March 16, 2022. On Tuesday March 26, 2024, the United States Supreme Court will have an impact on how women have access to the Mifepristone, one of the two pills used in the most current nation.

“There is a set of data in progress which enters the FDA on Miffepristone,” he said. “So, if the data suggest something or tell us that there is a real signal, we cannot promise that we will not be on this data.”

Senator Josh Hawley, R-MO., Wrote a letter of April 28 in Makary concerning the security problems concerning mifepristone.

The senator has legislation to brake a widely used controversial abortion pill

Dr. Makary is a cancer surgeon, a researcher at Johns Hopkins University, and was also a commentator of Fox News. (Getty Images)

“I urge you to follow this new data and take all appropriate measures to restore critical guarantees on the use of mifepristone. The health and safety of American women depend on it,” wrote Hawley.

Click here to obtain the Fox News app

Miffepristone (Mifeprex) and Misoprostol, the two drugs used in an abortion of drugs, are observed at the women’s breeding clinic, which provides abortions for legal drugs, in Santa Teresa, New Mexico, June 17, 2022. (Robyn Beck / AFP via Getty Images)

Makary said during the interview with Politico that he did not intend to “changes” with politics concerning mifepristone, adding that he would continue to listen to people who say they have concerns “.

Fox News Digital contacted the FDA and Senator Hawley to comment.